<div class="infobox infobox-protein"> | | | |---|---| | Protein Name | Paraoxonase 2 | | Gene Symbol | [PON2](/genes/pon2) | | UniProt ID | [Q15165](https://www.uniprot.org/uniprot/Q15165) | | Molecular Weight | ~39 kDa | | Subcellular Localization | Endoplasmic Reticulum, Mitochondria, Cytoplasm | | Protein Family | Paraoxonase family | | Tissue Expression | Brain, Heart, Liver, Kidney | | Enzyme Activity | Lactonase, Organophosphatase, Antioxidant | </div>
Paraoxonase 2 (PON2)
Overview
Paraoxonase 2 (PON2) is a 39 kDa intracellular enzyme belonging to the paraoxonase family, which also includes PON1 and PON3. Unlike its family members, PON2 is not secreted and resides primarily in the endoplasmic reticulum and mitochondria, where it provides crucial cellular protection against oxidative stress. PON2 possesses lactonase, organophosphate-hydrolyzing, and antioxidant activities that make it a significant player in neuroprotection.
PON2 is widely expressed in human tissues, with high levels in the brain, heart, liver, and kidneys. In the nervous system, PON2 is expressed in both [neurons](/cell-types/neurons) and [glial cells](/cell-types/glia), where it protects against mitochondrial dysfunction, reduces reactive oxygen species (ROS), and inhibits apoptosis. Reduced PON2 expression and activity have been implicated in the pathogenesis of Alzheimer's Disease, Parkinson's Disease, and other neurodegenerative disorders.
Structure and Enzyme Properties
...
<div class="infobox infobox-protein"> | | | |---|---| | Protein Name | Paraoxonase 2 | | Gene Symbol | [PON2](/genes/pon2) | | UniProt ID | [Q15165](https://www.uniprot.org/uniprot/Q15165) | | Molecular Weight | ~39 kDa | | Subcellular Localization | Endoplasmic Reticulum, Mitochondria, Cytoplasm | | Protein Family | Paraoxonase family | | Tissue Expression | Brain, Heart, Liver, Kidney | | Enzyme Activity | Lactonase, Organophosphatase, Antioxidant | </div>
Paraoxonase 2 (PON2)
Overview
Paraoxonase 2 (PON2) is a 39 kDa intracellular enzyme belonging to the paraoxonase family, which also includes PON1 and PON3. Unlike its family members, PON2 is not secreted and resides primarily in the endoplasmic reticulum and mitochondria, where it provides crucial cellular protection against oxidative stress. PON2 possesses lactonase, organophosphate-hydrolyzing, and antioxidant activities that make it a significant player in neuroprotection.
PON2 is widely expressed in human tissues, with high levels in the brain, heart, liver, and kidneys. In the nervous system, PON2 is expressed in both [neurons](/cell-types/neurons) and [glial cells](/cell-types/glia), where it protects against mitochondrial dysfunction, reduces reactive oxygen species (ROS), and inhibits apoptosis. Reduced PON2 expression and activity have been implicated in the pathogenesis of Alzheimer's Disease, Parkinson's Disease, and other neurodegenerative disorders.
Structure and Enzyme Properties
PON2 shares structural homology with other paraoxonases, adopting a six-bladed beta-propeller fold characteristic of the family. However, PON2 has several unique features:
Structural Features
Six-bladed beta-propeller: Catalytic core of the enzyme
Unique N-terminus: Lacks the N-terminal signal peptide present in PON1/PON3, explaining intracellular localization
Active site: Contains residues critical for lactonase and hydrolytic activity
Calcium requirement: Enzyme activity requires calcium ions for structural stability and catalysis
Enzymatic Activities
Lactonase activity: Hydrolyzes lactones including homocysteine thiolactone
Organophosphatase activity: Hydrolyzes organophosphates and nerve agents
Antioxidant activity: Prevents LDL oxidation and lipid peroxidation
Normal Physiological Function
Mitochondrial Protection
PON2 plays a critical role in maintaining mitochondrial function:
ROS reduction: PON2 inhibits mitochondrial ROS production by modulating Complex I activity
Apoptosis inhibition: PON2 prevents mitochondrial cytochrome c release and caspase activation
Autophagy regulation: PON2 participates in mitophagy and mitochondrial quality control
Endoplasmic Reticulum Function
In the ER, PON2:
Reduces ER stress markers
Modulates unfolded protein response (UPR)
Protects against ER-associated degradation (ERAD) dysfunction
Cellular Oxidative Stress Response
PON2 is upregulated under oxidative stress conditions:
Heat shock response activates PON2 expression
Nrf2 transcription factor regulates PON2
Cellular antioxidant systems work synergistically with PON2
Role in Neurodegenerative Diseases
Alzheimer's Disease
PON2 is increasingly recognized as important in AD pathogenesis:
Amyloid-beta toxicity: PON2 protects neurons from amyloid-beta-induced oxidative stress and cell death. Reduced PON2 makes neurons more vulnerable to Aβ toxicity.
Mitochondrial dysfunction: PON2 deficiency exacerbates mitochondrial dysfunction in AD, a hallmark of the disease. The protein helps maintain mitochondrial integrity.
Oxidative stress: AD brain shows elevated oxidative stress markers with corresponding reductions in PON2. The protein's antioxidant function is critical in countering this.
Tau pathology: PON2 may influence tau phosphorylation through its effects on mitochondrial function and cellular energetics.
Genetic associations: PON2 polymorphisms have been associated with AD risk in some populations.
Parkinson's Disease
In PD, PON2 plays protective roles:
Dopaminergic neuron survival: PON2 protects dopaminergic neurons from oxidative stress, which is particularly relevant given the high oxidative burden in these cells.
Mitochondrial complex I: PON2 modulates mitochondrial complex I activity, which is specifically impaired in PD.
Alpha-synuclein aggregation: PON2 may affect alpha-synuclein aggregation through its effects on cellular oxidative stress and protein quality control.
Neuroinflammation: PON2's anti-inflammatory properties may protect against glial activation in PD.
Amyotrophic Lateral Sclerosis (ALS)
PON2 is expressed in motor neurons
Provides protection against oxidative stress-induced motor neuron death
Altered expression in ALS patient tissues
Other Neurodegenerative Disorders
Huntington's Disease: PON2 may protect against mutant huntingtin-induced oxidative stress
Multiple Sclerosis: PON2 expression altered in demyelinating lesions
Friedreich's Ataxia: PON2 deficiency may contribute to mitochondrial dysfunction
Therapeutic Implications
PON2 represents a therapeutic target for neurodegenerative diseases:
Upregulation strategies: Compounds that increase PON2 expression could provide neuroprotection
Enzyme stabilization: Small molecules stabilizing PON2 activity
Gene therapy: Viral vector delivery of PON2
Antioxidant therapy: Enhancing overall cellular antioxidant capacity including PON2
Upregulating PON2
Statins: Some statins upregulate PON2 expression
Polyphenols: Flavonoids and other polyphenols increase PON2
Exercise: Physical activity upregulates PON2 in brain